glp-1 drug delivery devices Semaglutide vs. Other Receptor Agonists Oral GLP-1-Based Therapeutics in the
Description
Oskarsson, M
10.1038/s41419-019-1904-7 43 YueW.LiY.OuD.YangQ
Beyond genetic variability, differences in metabolic phenotype may significantly influence treatment response
However, clinically significant DDIs were observed with oral contraceptives after tirzepatide administration and with levothyroxine after oral semaglutide administration
6,18,19 Similar to sitagliptin, saxagliptin is excreted by the kidneys, but it also undergoes hepatic metabolism
